Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.005 Å; R factor = 0.075; wR factor = 0.175; data-to-parameter ratio = 15.2.
The title compound, C 13 H 18 N 2 O 3 , is an intermediate in the synthesis of compounds with medicinial applications. The crystal structure is stabilized by intermolecular N-HÁ Á ÁO, C-HÁ Á ÁN and C-HÁ Á ÁO hydrogen bonds.
Related literature
For bond-length data, see: Allen et al. (1987) . For related literature, see: Engeli et al. (2000) ; Goossens et al. (2003) ; Kintscher et al. (2004) ; Kurtz & Pravenec (2004) ; Ries et al. (1993) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). an angiotensin II receptor blocker, and in the development of obesity and related metabolic disorders in diet-induced obese mice (Ries et al., 1993) . Telmisartan can be used as a therapeutic tool for metabolic syndrome, including visceral obesity (Engeli et al., 2000; Kintscher et al., 2004; Goossens et al., 2003; Kurtz et al., 2004) . As part of our studies in this area, we report herein the synthesis and crystal structure of the title compound, (I).
In the molecule of (I) (Fig. 1) , bond lengths and angles are within normal ranges (Allen et al., 1987) . The aromatic ring (C3-C8) is, of course, planar.
The crystal structure is stabilized by intermolecular N-H···O, C-H···N and C-H···O hydrogen bonds (Table 1 Crystals of (I) suitable for X-ray diffraction were obstained by slow evaporation of an ethanolic solution.
Refinement
H atoms were positioned geometrically, with N-H = 0.86 Å (for NH) and C-H = 0.93, 0.98 and 0.96 Å for aromatic, methene and methyl H, and constrained to ride on their parent atoms, with U iso (H) = xU eq (C,N), where x = 1.5 for methyl H, and x = 1.2 for all other H atoms. Figures   Fig. 1 . The molecular structure of the title molecule, with the atom-numbering scheme. Displacement ellipsoids are drawn at the 30% probability level.
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